Inhibición de mTOR, proteínas AKT y enfermedad renal crónica
mTOR inhibition, AKT proteins and chronic kidney disease
Leído
18287
Vecesse ha leído el artículo
3398
Total PDF
14889
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 20 | 5 | 25 |
| 2025 10 | 139 | 43 | 182 |
| 2025 9 | 156 | 57 | 213 |
| 2025 8 | 101 | 48 | 149 |
| 2025 7 | 157 | 26 | 183 |
| 2025 6 | 207 | 110 | 317 |
| 2025 5 | 173 | 64 | 237 |
| 2025 4 | 128 | 20 | 148 |
| 2025 3 | 186 | 58 | 244 |
| 2025 2 | 120 | 49 | 169 |
| 2025 1 | 133 | 49 | 182 |
| 2024 12 | 102 | 29 | 131 |
| 2024 11 | 169 | 52 | 221 |
| 2024 10 | 129 | 33 | 162 |
| 2024 9 | 144 | 27 | 171 |
| 2024 8 | 99 | 65 | 164 |
| 2024 7 | 112 | 30 | 142 |
| 2024 6 | 129 | 49 | 178 |
| 2024 5 | 131 | 47 | 178 |
| 2024 4 | 183 | 43 | 226 |
| 2024 3 | 109 | 28 | 137 |
| 2024 2 | 84 | 31 | 115 |
| 2024 1 | 73 | 27 | 100 |
| 2023 12 | 70 | 31 | 101 |
| 2023 11 | 96 | 45 | 141 |
| 2023 10 | 116 | 37 | 153 |
| 2023 9 | 80 | 29 | 109 |
| 2023 8 | 70 | 27 | 97 |
| 2023 7 | 86 | 32 | 118 |
| 2023 6 | 101 | 20 | 121 |
| 2023 5 | 102 | 36 | 138 |
| 2023 4 | 68 | 17 | 85 |
| 2023 3 | 79 | 25 | 104 |
| 2023 2 | 89 | 26 | 115 |
| 2022 1 | 76 | 28 | 104 |
| 2022 12 | 85 | 29 | 114 |
| 2022 11 | 88 | 50 | 138 |
| 2022 10 | 95 | 66 | 161 |
| 2022 9 | 79 | 58 | 137 |
| 2022 8 | 62 | 42 | 104 |
| 2022 7 | 63 | 60 | 123 |
| 2022 6 | 66 | 49 | 115 |
| 2022 5 | 75 | 32 | 107 |
| 2022 4 | 54 | 49 | 103 |
| 2022 3 | 70 | 61 | 131 |
| 2022 2 | 63 | 52 | 115 |
| 2021 1 | 67 | 44 | 111 |
| 2021 12 | 62 | 52 | 114 |
| 2021 11 | 92 | 45 | 137 |
| 2021 10 | 138 | 40 | 178 |
| 2021 9 | 89 | 46 | 135 |
| 2021 8 | 58 | 37 | 95 |
| 2021 7 | 51 | 34 | 85 |
| 2021 6 | 61 | 26 | 87 |
| 2021 5 | 90 | 48 | 138 |
| 2021 4 | 152 | 75 | 227 |
| 2021 3 | 105 | 43 | 148 |
| 2021 2 | 95 | 27 | 122 |
| 2020 1 | 65 | 23 | 88 |
| 2020 12 | 80 | 16 | 96 |
| 2020 11 | 73 | 22 | 95 |
| 2020 10 | 84 | 20 | 104 |
| 2020 9 | 64 | 13 | 77 |
| 2020 8 | 61 | 18 | 79 |
| 2020 7 | 85 | 11 | 96 |
| 2020 6 | 66 | 22 | 88 |
| 2020 5 | 85 | 15 | 100 |
| 2020 4 | 87 | 18 | 105 |
| 2020 3 | 59 | 14 | 73 |
| 2020 2 | 68 | 21 | 89 |
| 2020 1 | 121 | 15 | 136 |
| 2019 12 | 120 | 24 | 144 |
| 2019 11 | 183 | 15 | 198 |
| 2019 10 | 112 | 8 | 120 |
| 2019 9 | 106 | 22 | 128 |
| 2019 8 | 73 | 16 | 89 |
| 2019 7 | 97 | 16 | 113 |
| 2019 6 | 110 | 15 | 125 |
| 2019 5 | 132 | 9 | 141 |
| 2019 4 | 78 | 25 | 103 |
| 2019 3 | 65 | 21 | 86 |
| 2019 2 | 52 | 24 | 76 |
| 2019 1 | 41 | 28 | 69 |
| 2018 12 | 117 | 51 | 168 |
| 2018 11 | 109 | 25 | 134 |
| 2018 10 | 112 | 14 | 126 |
| 2018 9 | 113 | 17 | 130 |
| 2018 8 | 93 | 19 | 112 |
| 2018 7 | 66 | 20 | 86 |
| 2018 6 | 95 | 17 | 112 |
| 2018 5 | 106 | 13 | 119 |
| 2018 4 | 97 | 20 | 117 |
| 2018 3 | 77 | 12 | 89 |
| 2018 2 | 80 | 8 | 88 |
| 2018 1 | 84 | 9 | 93 |
| 2017 12 | 85 | 12 | 97 |
| 2017 11 | 74 | 15 | 89 |
| 2017 10 | 68 | 8 | 76 |
| 2017 9 | 67 | 15 | 82 |
| 2017 8 | 54 | 25 | 79 |
| 2017 7 | 65 | 24 | 89 |
| 2017 6 | 69 | 36 | 105 |
| 2017 5 | 100 | 31 | 131 |
| 2017 4 | 79 | 25 | 104 |
| 2017 3 | 69 | 11 | 80 |
| 2017 2 | 116 | 12 | 128 |
| 2016 1 | 44 | 16 | 60 |
| 2016 12 | 106 | 14 | 120 |
| 2016 11 | 162 | 20 | 182 |
| 2016 10 | 193 | 22 | 215 |
| 2016 9 | 291 | 9 | 300 |
| 2016 8 | 347 | 10 | 357 |
| 2016 7 | 308 | 9 | 317 |
| 2016 6 | 204 | 0 | 204 |
| 2016 5 | 189 | 0 | 189 |
| 2016 4 | 192 | 0 | 192 |
| 2016 3 | 156 | 0 | 156 |
| 2016 2 | 189 | 0 | 189 |
| 2015 1 | 171 | 0 | 171 |
| 2015 12 | 170 | 0 | 170 |
| 2015 11 | 165 | 0 | 165 |
| 2015 10 | 199 | 0 | 199 |
| 2015 9 | 140 | 0 | 140 |
| 2015 8 | 142 | 0 | 142 |
| 2015 7 | 134 | 0 | 134 |
| 2015 6 | 89 | 0 | 89 |
| 2015 5 | 183 | 0 | 183 |
| 2015 4 | 50 | 0 | 50 |
| 2015 3 | 4 | 0 | 4 |
| 2015 2 | 1022 | 0 | 1022 |
Mostrar todo
